These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7084440)

  • 1. Further observations on the antispasmodic activity of rociverine.
    Coruzzi G; Adami M; Poli E; Bertaccini G
    Farmaco Prat; 1982 Apr; 37(4):109-15. PubMed ID: 7084440
    [No Abstract]   [Full Text] [Related]  

  • 2. Antispasmodic activity of rociverine on the smooth musculature of the urinary tract. Comparative in vitro study.
    Schiantarelli P; Murmann W
    Arzneimittelforschung; 1980; 30(7):1102-9. PubMed ID: 7191292
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of smooth muscle relaxation by rociverine.
    D'Agostino G; Zonta F; Santagostino Barbone MG; Grana E; Brunori P; Subissi A
    Arzneimittelforschung; 1984; 34(5):584-9. PubMed ID: 6540576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of rociverine + dipyrone for antispasmodic and analgesic interactions.
    Schiantarelli P; Murmann W; Magi S
    Arzneimittelforschung; 1979; 29(5):760-5. PubMed ID: 582975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystometric evaluation of the activity of a new spasmolytic agent - rociverine.
    Manganelli A
    Farmaco Prat; 1979 Sep; 34(9):384-92. PubMed ID: 553816
    [No Abstract]   [Full Text] [Related]  

  • 6. Rociverine compared with other spasmolytics for cardiovascular effects.
    Guelfi M; Schiantarelli P; Subissi A
    Farmaco Prat; 1981 Aug; 36(8):374-82. PubMed ID: 7274417
    [No Abstract]   [Full Text] [Related]  

  • 7. Rociverine, a new antispasmodic agent with balanced neurotropic and myotropic activity.
    Toson G; Schiantarelli P; Murmann W
    Arzneimittelforschung; 1978; 28(7):1130-42. PubMed ID: 582702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of a new spasmolytic agent, rociverine, on intraocular pressure, pupil size and iridocorneal angle in patients with angle-closure glaucoma.
    Pardini M; Saponati G
    Pharmatherapeutica; 1983; 3(7):445-50. PubMed ID: 6669589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rociverine and other spasmolytic agents on caerulein-induced delay in gastric emptying in the conscious rat.
    Subissi A; Guelfi M
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):130-7. PubMed ID: 7114969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rociverine citrate: a new spasmolytic agent, potentially useful in the treatment of urinary bladder hyperreflexia.
    Subissi A; Maggi CA; Meli A
    Jpn J Pharmacol; 1986 Oct; 42(2):153-7. PubMed ID: 3540391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antispasmodic activity of rociverine. Manometric findings and controlled clinical trial.
    Lanfranchi GA; Marzio L; Campieri M; Brignola C; Trento L
    Panminerva Med; 1980 Jan-Mar 22; 22(1):7-12. PubMed ID: 6997806
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of a new antispasmodic drug, rociverine, in dynamic dystocia].
    Pardini I; Maresi MP
    Minerva Ginecol; 1980 Sep; 32(9):831-6. PubMed ID: 7219836
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of rociverine on the human ureter: in vivo and in vitro experimental study.
    Potenzoni D; Zappia L; Sacchini P; Bezzi E
    Pharmacol Res Commun; 1984 Aug; 16(8):765-74. PubMed ID: 6494219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparisons of effects of Hoe-498 and enalapril in isolated guinea pig hearts and rat myocardium].
    Xiang JZ; Schölkens BA; Linz W; Unger T; Ganten D; Lang RE
    Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):96-9. PubMed ID: 3002124
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of a new antispasmotic, rociverine, in the radiologic examination of the duodenum].
    De Miranda B; La Ragione M
    Farmaco Prat; 1981 Apr; 36(4):228-32. PubMed ID: 7227498
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of a new synthetic spasmolytic (rociverine) in the urological field.
    Laudi M; Fontana G
    Farmaco Prat; 1979 Dec; 34(12):553-60. PubMed ID: 553813
    [No Abstract]   [Full Text] [Related]  

  • 17. [Instrumental and clinical study of rociverine].
    Testa R; Dellepiane F; Ciravegna G
    Clin Ter; 1980 May; 93(3):311-7. PubMed ID: 7449344
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of syntropium bromide as an antispasmodic].
    Galeone M; Cacioli D; Moise G; Bossi M; Benazzi E; Monti G
    Minerva Med; 1985 Sep; 76(36):1605-10. PubMed ID: 3900811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectlessness of a new spasmolytic (rociverine) on intraocular pressure, pupil size, and iridocorneal angle in ophthalmically healthy subjects.
    Pardini M; Saponati G
    Clin Ther; 1981; 4(1):48-55. PubMed ID: 7273068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies into the ECG effects of tedisamil (KC 8857) in rats.
    Howard PG; Abraham S; Courtice ID; Walker MJ
    Proc West Pharmacol Soc; 1989; 32():183. PubMed ID: 2780585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.